MARSHALL WACE, LLP

Position in CNMD — CONMED Corp

CIK 1318757 LONDON, X0

Position in CNMD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$5,742,608

-$295,323 QoQ

Shares Held

175,454

+2.8% QoQ

Ownership

0.586%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#36

of 245 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. CNMD ranks #19 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	5,542,438	$502,920,823
2	BSX	Boston Scientific Corp	2,414,223	$103,039,037
3	GKOS	GLAUKOS Corp	314,804	$43,997,006
4	DXCM	Dexcom Inc	532,804	$35,884,349
5	EW	Edwards Lifesciences Corp	344,361	$31,150,895
6	PEN	Penumbra Inc	90,520	$28,581,689
7	SYK	Stryker Corp	51,116	$16,093,361
8	GMED	Globus Medical Inc	188,541	$14,896,623

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,742,608	175,454	+2.8%	Shares	Other	2026-08-13
2026-03-31	$6,037,931	170,756	-23.2%	Shares	Other	2026-05-15
2025-12-31	$9,028,870	222,386	+5589.1%	Shares	Other	2026-02-13
2025-03-31	$236,064	3,909	-47.2%	Shares	Other	2025-05-15
2024-09-30	$532,279	7,401	-90.2%	Shares	Other	2024-11-14
2024-06-30	$5,227,767	75,415	+42.1%	Shares	Other	2024-08-14
2024-03-31	$4,251,367	53,089	+46.6%	Shares	Other	2024-05-15
2023-12-31	$3,965,685	36,213	+149.3%	Shares	Other	2024-02-14
2023-09-30	$1,465,148	14,528	+136.0%	Shares	Other	2023-11-14
2023-03-31	$639,362	6,156	-94.9%	Shares	Other	2023-05-15
2020-06-30	$8,689,552	120,705	-17.8%	Shares	Sole	2020-08-13
2020-03-31	$8,407,636	146,807	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.